Cargando…

Steroid hormone synthesis is impaired in patients with severe sepsis

Detalles Bibliográficos
Autores principales:	Angstwurm, M, Rashidi Kia, A, Schopohl, J, Gaertner, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301448/ http://dx.doi.org/10.1186/cc1892

Ejemplares similares

Hormones and not gender influences outcome in severe infection
por: Angstwurm, M, et al.
Publicado: (2001)

Selenium substitution in patients with severe systemic inflammatory response syndrome (SIRS)
por: Angstwurm, MWA, et al.
Publicado: (1998)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Complement activation in relation to age in patients with severe sepsis
por: Marx, G, et al.
Publicado: (2002)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Nutritional parameters in patients with severe catabolism due to trauma or sepsis
por: Gallioli, G, et al.
Publicado: (1997)

An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Comparing the effects of dopexamine and dobutamine on splanchnic parameters in patients with severe sepsis
por: Esen, F, et al.
Publicado: (1998)

Sepsis: cause of late deterioration of intracranial pressure in patients with severe traumatic brain injury?
por: Dostal, P, et al.
Publicado: (1998)

C5a receptor expression on leukocytes from patients with severe sepsis or septic shock
por: Furebring, M, et al.
Publicado: (2001)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

Inclusion criteria in sepsis trials should include severity of organ dysfunction
por: Taneja, R, et al.
Publicado: (2001)

Initial plasma levels of lipopolysaccharide binding protein are associated with severe sepsis in patients with community-acquired pneumonia
por: Martino, ML, et al.
Publicado: (2003)

Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
por: Launois, R, et al.
Publicado: (2002)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

Monoethylglycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis
por: Esen, F, et al.
Publicado: (1997)

Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
por: Ring, Alicia, et al.
Publicado: (2011)

Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Use of anabolic steroid therapy in critically ill ICU patients
por: Pikul, J, et al.
Publicado: (2003)

CD64 upregulation on peripheral granulocytes is not a marker of sepsis and does not correlate with serum concentrations of granulocyte colony-stimulating factor (G-CSF) in postoperative/posttraumatic patients with severe sepsis
por: Weiss, M, et al.
Publicado: (1998)

Quality of life in ICU survivors with severe sepsis who received activated protein C
por: Cook, WT, et al.
Publicado: (2003)

Important factors for the modelling and design of clinical trials for severe sepsis and multiple organ failure
por: Shaikh, L, et al.
Publicado: (1999)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

Early-onset thrombocytopenia, severe polyarthritis, and severe Β cell impairment in a Down syndrome patient
por: Willy-Fabro, Ana Paula, et al.
Publicado: (2015)

Evaluating the effect of steroids on the incidence of reintubation rates in children with laryngotracheobronchitis
por: Rajah, J, et al.
Publicado: (1999)

SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997)

Mobilization of leukocytes in patients with severe sepsis and septic shock is associated with increased apoptosis, as detected by Annexin V binding
por: Weiss, M, et al.
Publicado: (2001)

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock
por: Huang, DT, et al.
Publicado: (2003)

Hypersensitivity to non-steroidal anti-inflammatory drugs in pediatric patients
por: Lacerda, Alex, et al.
Publicado: (2015)

Impaired PMN migratory capacity: a risk marker for impending infections in severe trauma patients
por: Mitterhammer, H, et al.
Publicado: (2003)

Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2001)

Increased monocyte activation and tissue factor expression in patients with sepsis
por: Dohrn, B, et al.
Publicado: (1998)

Cytokines and sepsis
por: Marum, S, et al.
Publicado: (1999)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Characteristics of patients with sepsis and multiple organ failure in the UK
por: Shaikh, L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_22blf2t3h49eegn6cfv5g4e378